CVRdatabase
Menu

Cirqle Biomedical Contraception ApS

Private limited companyCVR 39865769København NActive

Cirqle Biomedical Contraception ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2018. The company went from a profit in 2024 to a loss of DKK 6.4m in 2025. Equity fell to DKK 29.5m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 2.4m−104% vs. 2024
Net profit−DKK 6.4m−114.8% vs. 2024
EquityDKK 29.5m−17.8% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 104% (2024 → 2025), to −DKK 2.4m.
  • Net profit went from a profit of DKK 43.4m to a loss of DKK 6.4m (2024 → 2025).
  • Equity fell 18% (2024 → 2025), to DKK 29.5m.

Employees

  • 3 fewer employees than a year earlier: 2 (07/2026) against 5 (07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
EquityNet profit
Financial figures for Cirqle Biomedical Contraception ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−4,133−5,76962,142−12,84860,579−2,427−104%
Operating profit (EBIT)−6,313−8,49858,743−21,23653,098−6,358−112%
Profit before tax−6,715−8,78158,368−20,78855,372−7,187−113%
Net profit−5,558−7,20847,682−15,98543,425−6,410−114.8%
Total assets10,7833,62870,21945,93639,47631,468−20.3%
Equity2,844−4,36450,35134,36635,93129,521−17.8%
Liabilities7,9387,99219,86811,5693,5391,947−45%
Cash and cash equivalents9,0371,51257,46039,81435,85729,361−18.1%
Average number of employees555974−42.9%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Annual reports

6 financial years
Annual reports for Cirqle Biomedical Contraception ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202414/04/2025The companyPDFXBRL
202301/01/2023 – 31/12/202328/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202228/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202128/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202028/04/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0246810121408/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 2.4mNo. 353 of 421
Better than 16% of the companies in the industry
EquityDKK 29.5mNo. 84 of 431
Better than 81% of the companies in the industry
Number of employees2No. 224 of 431
Better than 48% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,277of 69,742
Better than 1%
No. 4,520of 69,964
Better than 94%
Same industry and fewer than 20 employees329 companies in the comparison
No. 274of 323
Better than 15%
No. 28of 329
Better than 92%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,325of 33,588
Better than 1%
No. 1,758of 33,687
Better than 95%
All companies of type ApS66,508 companies in the comparison
No. 65,997of 66,379
Better than 1%
No. 3,205of 66,505
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Cirqle Biomedical Contraception ApS−DKK 2.4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Cirqle Biomedical Contraception ApS−DKK 6.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Cirqle Biomedical Contraception ApSDKK 29.5m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Cirqle Biomedical Contraception ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Cirqle Biomedical Holding ApS66.67%
  • RH Capital Fund Ii, LP5%
Cirqle Biomedical Contraception ApS

Management

5 active registrations

Executive management

Executive management at Cirqle Biomedical Contraception ApS
NameRoleAppointed
Thomas CrouzierDirector11/09/2018
Frederik Petursson MadsenCEO17/09/2020

Board of directors

Board of directors at Cirqle Biomedical Contraception ApS
NameRoleAppointed
Frederik Petursson MadsenBoard member17/09/2020
Jesper BoysenChair of the board17/09/2020
Thomas CrouzierBoard member17/09/2020
Founders
MICOCOU Invest ApS, JD Tech Holding IVS, Cirqle Biomedical Holding ApS
Former management (1)
Former management at Cirqle Biomedical Contraception ApS
NameRoleAppointedResigned
Frederik Petursson MadsenDirector11/09/201816/09/2020

Signing rule: Selskabet tegnes af bestyrelsesformanden og den administrerende direktør i forening, den administrerende direktør og et bestyrelsesmedlem i forening, eller to bestyrelsesmedlemmer og den administrerende direktør i forening.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
Cirqle Biomedical Contraception ApSOle Maaløes Vej 3, 3, 2200 København N31023958763

Purpose

Selskabets formål er at undersøge, udvikle og kommercialisere ny teknologi omkring præventionsmidler.

The purpose is quoted from the register in Danish.

Changes year by year

24 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changescapital 1 · accounts 1
  • Share capital changed from 44,171 DKK to 45,059 DKK
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20223 changescapital 1 · ownership 1 · accounts 1
  • Share capital changed from 40,000 DKK to 44,171 DKK
  • RH CAPITAL FUND II, LP registered as owner (5%)
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20207 changesname 1 · capital 1 · management 5
  • Name changed from Cirqle Biomedical Contraception IVS to Cirqle Biomedical Contraception ApS
  • Share capital changed from 1,000 DKK to 40,000 DKK
  • Frederik Petursson Madsen appointed ceo
  • Frederik Petursson Madsen appointed board member
  • Jesper Boysen appointed chair of the board
  • Thomas Crouzier appointed board member
  • Frederik Petursson Madsen stepped down as director
20193 changescapital 1 · address 1 · name 1
  • Share capital changed from 2 DKK to 1,000 DKK
  • Moved to Ole Maaløes Vej 3, 3, 2200 København N
  • Name changed from Circle Biomedical Contraception IVS to Cirqle Biomedical Contraception IVS
20184 changesfounded 1 · management 2 · ownership 1
  • Registered as Circle Biomedical Contraception IVS
  • Frederik Petursson Madsen appointed director
  • Thomas Crouzier appointed director
  • Cirqle Biomedical Holding ApS registered as owner (66.67%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction